- 06:31 PM Mkts overreacting to Dubai crisis: Expert
- 06:11 PM Aegon Religare favours power sector stocks
- 06:10 PM French anti-racist body files complaint over Juve ...
- 06:10 PM BMW agree deal with Peter Sauber to save F1 team
- 06:00 PM MFs net sell Rs 257.50 cr in equities on Nov 26
- 05:59 PM F&O Check: Nifty 4900 Call adds 14 lk shares in OI
- 05:59 PM MBL Infrastructures IPO richly priced: Angel Broki...
- 05:54 PM FIIs net buy Rs 306.10 cr in equities on Nov 26
- 05:47 PM Avoid MBL Infra IPO: Hem Securities
- 05:41 PM BSEL Ajmam exposure unaffected by Dubai debt crise...
Aurobindo Pharma Limited is pleased to announce that the company has received tentative approval from the US Food & Drug Administration to manufacture and market Sumatriptan Succinate Tablets 25mg, 50mg and 100mg.
Sumatriptan Succinate Tablets are the generic equivalent of GlaxoSmithKline's Imitrex® Tablets, which are indicated for the treatment of acute migraine headaches.
Annual sales of Sumatriptan Succinate Tablets 25mg, 50mg and 100m. in the US were approximately US$ 950 million for the twelve months ending MAT/3/2007 according to IMS Health data
This is Aurobindo’s 63rd ANDA approval from the USFDA
Sourced From: Aurobindo Pharma Limited
Business
Business News | Economy | Earnings | BSE NSE Notices
General News
Current Affairs | Politics | World News | Sports | Entertainment
Corporate Strategy
Management | Advertising | Marketing | Legal
Personal Finance
Tax | Insurance | Credit Cards | Loans | Property | Retirement | Investment Help | Financial Planning | Fixed Income
Markets
Local Market | Global Market | Market Cues | Analysis | Expert & FII outlook | Brokerage Recomendation
Stocks
Stocks in News | Expert Advice | ADRs & GDRs | IPO
Mutual Funds
News | Advice | MF Analysis | Fund Managers Views
Lifestyle
Travel | Wellness | Technology | Auto| Books
-
Most Read
-
Most Viewed
- 10 Companies that FIIs love
- 10 companies that MF managers love
- Dubai crisis: Which Indian companies may be affected
- Dubai jitters: Will bears overtake investor confidence now?
- Global mkts panic on Dubai's debt rescheduling
- Indian mkts rattled from Dubai default impact
- Ganeshaspeaks: Market prediction for Nov 27
- Ashwani Gujral's top five picks for today's trade
- Nifty slips over 2%, breaches 4900 on Dubai's debt concerns
- MBL Infra IPO opens; should you subscribe?
- Lanco Infra tying up funds for three power projects
Source: Business Line
- RIL units to get 20% of gas needs from D-6
Source: Business Line
- No need to ban cotton export, says Maran
Source: Business Line
- Karnataka hikes power tariff by 34.16 paise/unit
Source: Business Line
